The five-year survival rate for people diagnosed with the most advanced stage of non-small cell lung cancer (NSCLC) is pretty grim, only between one and 10 percent. To address this devastating condition, the Board of the California Institute for Regenerative Medicine (CIRM) today voted to invest almost $12 million in a team from UCLA that … Continue reading CIRM invests in stem cell clinical trial targeting lung cancer and promising research into osteoporosis and incontinence
ICOC Board Meetings
Budget for CIRM’s Future
The CIRM Board discusses the future of the Stem Cell Agency Last week the California Institute for Regenerative Medicine's looked at what the stem cell agency has in the back, and set out a plan to budget for CIRM's future. Last year CIRM spent about $306 million on a wide range of research. That leaves … Continue reading Budget for CIRM’s Future
March ICOC/Governing Board Meeting Begins Soon
The March ICOC/Governing Board Meeting is beginning this morning at 9am in Berkeley, CA. Agenda details and dial-in instructions can be found on our website. Please watch this space for an update from the meeting. You can also keep up with the latest news by visiting CIRM on Twitter and Facebook.
January ICOC Board Meeting To Begin Soon
The January ICOC Board Meeting begins this morning in San Francisco, CA. The complete agenda and dial-in instructions can be found here. Stay tuned for updates after the meeting!